Size and Importance of Socioeconomic Status-Based Disparities in Use of Surgery in Nonadvanced Stage Gastrointestinal Cancers

被引:40
作者
Swords, Douglas S. [1 ]
Mulvihill, Sean J. [1 ]
Brooke, Benjamin S. [1 ]
Firpo, Matthew A. [1 ]
Scaife, Courtney L. [1 ]
机构
[1] Univ Utah, Dept Surg, Salt Lake City, UT 84112 USA
关键词
PANCREATIC ADENOCARCINOMA; SURVIVAL; CALIFORNIA; MORTALITY; FAILURE; OPERATE; RATIOS; BREAST;
D O I
10.1245/s10434-019-07922-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The size and importance of socioeconomic status (SES)-based disparities in use of surgery for non-advanced stage gastrointestinal (GI) cancers have not been quantified. Methods The exposure in this study of patients age 18-80 with one of nine non-advanced stage GI cancers in the 2007-2015 SEER database was a census tract-level SES composite. Multivariable models assessed associations of SES with use of surgery. Causal mediation analysis was used to estimate the proportion of survival disparities in SES quintiles 1 versus 5 that were mediated by disparities in use of surgery. Results Lowest SES quintile patients underwent surgery at significantly lower rates than highest quintile patients in each cancer. SES-based disparities in use of surgery were large and graded in esophagus adenocarcinoma, intrahepatic and extrahepatic cholangiocarcinoma, and pancreatic adenocarcinoma. Smaller but clinically relevant disparities were present in stomach, ampulla, and small bowel adenocarcinoma, whereas disparities were small in colorectal adenocarcinoma. Five-year all-stage overall survival (OS) was correlated with the size of disparities in use of surgery in SES quintiles 1 versus 5 (r = - 0.87; p = 0.003). Mean OS was significantly longer (range 3.5-8.9 months) in SES quintile 5 versus 1. Approximately one third of SES-based survival disparities in poor prognosis GI cancers were mediated by disparities in use of surgery. The size of disparities in use of surgery in SES quintiles 1 versus 5 was correlated with the proportion mediated (r = 0.98; p < 0.001). Conclusions Low SES patients with poor prognosis GI cancers are at substantial risk of undertreatment. Disparities in use of surgery contribute to diminished survival.
引用
收藏
页码:333 / 341
页数:9
相关论文
共 33 条
[1]  
[Anonymous], CENS TRACK LEV SES D
[2]  
[Anonymous], CENS TRACTS
[3]   Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy [J].
Baugh, Katherine A. ;
Cao, Hop S. Tran ;
van Buren, George, II ;
Silberfein, Eric J. ;
Hsu, Cary ;
Chai, Christy ;
Barakat, Omar ;
Fisher, William E. ;
Massarweh, Nader N. .
SURGERY, 2019, 165 (02) :307-314
[4]   National failure to operate on early stage pancreatic cancer [J].
Bilimoria, Karl Y. ;
Bentrem, David J. ;
Ko, Clifford Y. ;
Stewart, Andrew K. ;
Winchester, David P. ;
Talamonti, Mark S. .
ANNALS OF SURGERY, 2007, 246 (02) :173-180
[5]   Increasing Disparities in Mortality by Socioeconomic Status [J].
Bosworth, Barry .
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 39, 2018, 39 :237-251
[6]   Med4way: a Stata command to investigate mediating and interactive mechanisms using the four-way effect decomposition [J].
Discacciati, Andrea ;
Bellavia, Andrea ;
Lee, Jane J. ;
Mazumdar, Maitreyi ;
Valeri, Linda .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2019, 48 (01) :15-20
[7]   Failure to operate on resectable gastric cancer: implications for policy changes and regionalization [J].
Frohman, Heather A. ;
Martin, Jeremiah T. ;
Anh-Thu Le ;
Dineen, Sean P. ;
Tzeng, Ching-Wei D. .
JOURNAL OF SURGICAL RESEARCH, 2017, 214 :229-239
[8]   Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States) [J].
Liu, LH ;
Deapen, D ;
Bernstein, L .
CANCER CAUSES & CONTROL, 1998, 9 (04) :369-380
[9]   Underutilization of Treatment for Regional Gastric Cancer Among the Elderly in the USA [J].
Liu, Natalie ;
Molena, Daniela ;
Stem, Miloslawa ;
Blackford, Amanda L. ;
Sewell, David B. ;
Lidor, Anne O. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (06) :955-963
[10]   Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Lordick, F. ;
Mariette, C. ;
Haustermans, K. ;
Obermannova, R. ;
Arnold, D. .
ANNALS OF ONCOLOGY, 2016, 27 :v50-v57